LB-100 is a selective catalytic PP2A inhibitor. It affects Wnt/β-catenin and mTORC1 signaling pathways, and by inhibiting PP2A enzymatic activity, it inhibits tumor proliferation and EMT, and promotes immune cell activation.
LB-100 IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for LB-100 Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- LB-100 Mechanism of Action: PP2A Inhibition in Tumor Cell Research
- LB-100 Clinical Trials
- LB-100 Working Concentration | Cell Culture | Treatment
- LB-100 Solubility in DMSO
- LB-100 Stock Solution
- LB-100 Storage
- LB-100 Stability
- LB-100 Combination Database
- LB-100 Molecular Weight
- LB-100 SMILES
- LB-100 CAS Number
- LB-100 Chemical Structure (2D and 3D)
- LB-100 Sigma (XPIH9BCF735D)? Try a better option.
- LB-100 MedChemExpress (HY-18597)? Try a better option.
- LB-100 Cayman (29105)? Try a better option.
- LB-100 APExBIO (B4846)? Try a better option.
- LB-100 SDS｜MSDS